JPM vs CME
By Alex · Tickerpine
JP Morgan Chase & Co. vs CME Group Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JPM | CME |
|---|---|---|
| Price | $365.18 | $262.17 |
| Market cap | $970.72B | $94.27B |
| P/E ratio | 15.5 | 22.0 |
| ROE | 17.79% | 15.80% |
| Profit margin | 34.92% | 63.44% |
| Revenue growth | 30.40% | 0.80% |
| Dividend yield | 1.64% | 2.01% |
| Beta | 0.98 | 0.27 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JPM vs CME in plain English
- JPM is the bigger company — about 10.3× the market cap of CME.
- JPM is cheaper on earnings (P/E 15.5 vs 22.0).
- JPM earns a higher return on equity (18% vs 16%).
- JPM is growing revenue faster (30% vs 1%).
- CME has the higher dividend yield (2.01% vs 1.64%).
How would $1,000 have done in each?
JPM return calculator
See what $1,000 in JP Morgan Chase & Co. would be worth today.
CME return calculator
See what $1,000 in CME Group Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.